With less than 2.5 million shares outstanding, they've traded over 17 million shares today, clearly we have some major traders, perhaps Institutions, that are working the stock. I believe it was seriously undervalued since the time the hearing trial resumed, as the price was near $1.50 when that occurred, which would be $15 post reverse split. This rally could still have a way to go without real news.
The one thing I've seen was a current publication on the Yahoo message board on the superiority of GNVC's FMD vaccine. I don't know if this is a prelude to Merial bringing those vaccines to market. If so, GNVC will begin to have a revenue stream that no one has anticipated.
I've seen one Institution that's announced holding in GNVC, I suspect we'll see more as individual investors sell, and Institutions buy. If GNVC has any success whatsoever in any of it's developmental programs, it should achieve a market cap that's approaching a billion dollars, and could easily exceed it. While share count will no doubt be well over the current level, I believe it's currently limited to roughly 50 million shares, and it could remain under say 25 million shares for several years. I believe it still has tremendous upside potential.
Gary |
